| DCVAX Northwest Biotherapeutics, Inc. 1627849 11 Jun 2014 | Registered: Registered/protected | Immune cells, namely cells for medical or veterinary use; biotechnolog... Class 005 Class 005 Pharmaceutical Products Immune cells, namely cells for medical or veterinary use; biotechnology preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; medical preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators; derivatives and modulators of immune cells, namely, vaccines, proteins, peptides, enzymes, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for medical or veterinary use; vaccines | |
